You are here : Home > INDUSTRIAL INNOVATION > INNOVATE WITH CEA- LETI > Medtech Entrepreneur-In-Residence program

Article | Articles & files | Innovation for industry

 Medtech Entrepreneur-In-Residence program

The Medtech Entrepreneur-In-Residence program helps bring to market creative devices and solutions that will address tomorrow’s healthcare challenges

Published on 16 August 2018

Medtech Entrepreneur-In-Residence Program to Create Startups with Innovative Healthcare Solutions.

For the second consecutive year, Leti offers a Medtech Entrepreneur-In-Residence Program. Through the first program, an IoT project for healthcare applications has been selected, involving a senior medtech engineer and a clinician. The project is currently under incubation.

Entrepreneurs who qualify to join the program will have access to Leti's state-of-the-art technological, preclinical and clinical platforms and its knowhow to design and create products or solutions and launch disruptive startups. Leti helps develop medical technology leveraging its researchers' expertise and multidisciplinary approach, its infrastructure and its strong relationships with leading medical-industry partners.

Selected entrepreneurs will benefit from incubation periods ranging from 6 to 12 months, that includes:

  • Access to Leti's research teams, laboratories and technical expertise (state-of-the-art clean-rooms, photonics, biological, chemistry, microfluidic, electronic, modeling, characterization, clinical and pre-clinical facilities)
  • Identification of relevant Intellectual Property from Leti's portfolio of 2,760 patents
  • Resources for the joint development of an IP-based proof-of-concept for the target market and application
  • Access to Leti's startup program, and potentially to its partners' mentorship programs, on a case-by-case basis.

For this second edition, Leti targets solutions that meet medical, industrial and societal needs, including: 

  • Point-of-Care diagnosis
  • Internet of Things (IoT) for healthcare, from prevention to treatment
  • Medical Devices for innovative therapies such as drug delivery, physical effectors and bioelectronics.
  • Medical devices for exposome monitoring (environmental exposure)

To apply, download and fill out the form located in the top-right corner of this page.

Applications must be recieved by December 1st, 2018.